Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism.
about
Neuroimaging in pre-motor Parkinson's diseaseNeuropsychological performance in LRRK2 G2019S carriers with Parkinson's diseaseReorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneExperience-dependent modulation of alpha and beta during action observation and motor imagery.Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Emerging therapies for gait disability and balance impairment: promises and pitfalls.Targeting leucine-rich repeat kinase 2 in Parkinson's disease.A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study.Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?Intact working memory in non-manifesting LRRK2 carriers--an fMRI study.Lateral occipitotemporal cortex (LOTC) activity is greatest while viewing dance compared to visualization and movement: learning and expertise effects.The spectrum of preclinical gait disorders in early Parkinson's disease: subclinical gait abnormalities and compensatory mechanisms revealed with dual tasking.A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers
P2860
Q33676222-40F99C45-E43F-48C6-830B-5F1381A60FFEQ35013928-23A3A6A4-73E9-454B-828A-719394E88C2FQ35106295-728B6572-3E50-428D-B952-27788AD51CD2Q35772821-5A900B6E-0246-4BA2-B51C-EBEF5D3A6760Q36298749-C3DAD683-369B-4B45-AD3C-7813802D9BA6Q37385032-8A692BCD-5DCD-4D8A-A550-F94CCFA2DCFAQ38153332-21ECB4DD-E610-42A6-ADAC-D9DC2FCEE53AQ38160939-93513B6D-B92C-4DC1-A65C-2B363C199FECQ38843010-4F06980C-9579-416C-8D2D-40BA2870A462Q38859352-4DA3FD4E-51AE-4B5E-8577-32119D711E47Q39366467-363058DA-D909-49F3-8B3B-6D370DB5123AQ41261915-AFBC714F-B1A3-4908-8294-915099765721Q47972063-26414611-350B-4CE6-A3BA-D142DDC509FBQ48848140-E48994A1-D107-47F4-AA8F-4FA1FA52AE63Q50489508-A9AB8FB8-AE7D-40A5-8A99-0373C1B999B6Q57869557-7D0CEF72-C205-4190-9106-A9912080C04E
P2860
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@en
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@nl
type
label
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@en
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@nl
prefLabel
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@en
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cerebral pathological and comp ...... repeat kinase 2 parkinsonism.
@en
P2093
Anat Mirelman
Avner Thaler
Bart F L van Nuenen
Bart P C van de Warrenburg
Karen S Marder
LRRK2 Ashkenazi Jewish Consortium
Murielle Ferraye
Susan Bressman
P2860
P304
P356
10.1093/BRAIN/AWS288
P407
P577
2012-12-01T00:00:00Z